...
机译:腔内重组组织纤溶酶原激活剂治疗动脉瘤静脉内出血:META分析
Zhejiang Univ Sch Med Affiliated Hosp 2 Dept Neurosurg Hangzhou 310009 Zhejiang Peoples R;
Zhejiang Univ Sch Med Affiliated Hosp 2 Dept Neurosurg Hangzhou 310009 Zhejiang Peoples R;
Zhejiang Univ Sch Med Affiliated Hosp 2 Dept Neurosurg Hangzhou 310009 Zhejiang Peoples R;
Loma Linda Univ Dept Physiol &
Pharmacol Loma Linda CA 92350 USA;
Zhejiang Univ Sch Med Affiliated Hosp 2 Dept Neurosurg Hangzhou 310009 Zhejiang Peoples R;
Zhejiang Univ Sch Med Affiliated Hosp 2 Dept Neurosurg Hangzhou 310009 Zhejiang Peoples R;
Aneurysm; intraventricular hemorrhage; meta-analysis; recombinant tissue plasminogen activator; subarachnoid hemorrhage;
机译:腔内重组组织纤溶酶原激活剂治疗动脉瘤静脉内出血:META分析
机译:用重组组织纤溶酶原激活剂治疗脑室内溶栓的队列研究。
机译:脑室内施用重组组织纤溶酶原激活剂治疗脑室内出血18例临床研究。
机译:对重组组织纤溶酶原激活剂(RTPA)的对鸟类诱导的鸟类诱导的眼内出血进行调查
机译:MR引导的高强度聚焦超声在脑室内出血性血栓溶栓治疗中的可行性
机译:颅内动脉瘤破裂继发的脑室内出血-通过动静脉畸形栓塞及脑室内组织纤溶酶原激活剂成功治疗:病例报告
机译:继发于患有内腔动脉瘤的脑室出血性抗静无常的管理,通过动脉畸形栓塞,然后是腔内组织纤溶酶原激活剂